Sagility Limited announced that its wholly-owned subsidiary, Sagility (US) Holdings Inc., has entered into a definitive agreement to acquire Chirok Health LLC. The total consideration for the acquisition could reach up to US$ 32.35 million. This strategic move aims to strengthen Sagility’s capabilities in the healthcare services sector, particularly in specialized areas like Clinical Documentation Integrity (CDI) and medical coding.
Sagility Acquires Chirok Health LLC
Sagility Limited has disclosed that its wholly-owned subsidiary, Sagility (US) Holdings Inc., has proposed an acquisition/investment in Chirok Health LLC. A definitive agreement was signed on October 21, 2026, outlining the terms of this significant transaction. The acquisition is intended to bolster Sagility’s existing healthcare services portfolio by integrating specialized capabilities.
Strategic Rationale and Deal Terms
The primary objective of this acquisition is to enhance Sagility’s offerings in the provider segment. Specifically, it will add specialized Clinical Documentation Integrity (CDI) and medical coding expertise, complementing the company’s current services. The total purchase consideration for Chirok Health LLC is set at a maximum of US$ 32.35 million. This amount comprises an upfront payment of US$ 20.0 million at closing, subject to customary adjustments, and a contingent consideration of up to US$ 12.35 million, payable upon the achievement of specified performance milestones.
Target Entity Profile
Chirok Health LLC operates in the healthcare services industry, focusing on Revenue Cycle Management (RCM), Clinical Documentation Integrity (CDI), and medical coding services. The company was incorporated in 2019 and is headquartered in Tennessee, United States. For the fiscal year CY2025, Chirok reported a turnover of US$ 9.0 million. The company is 100% acquired, with the deal expected to be completed by October 21, 2026.
Source: BSE
